Evaluation of Hemostasis in Bleeding and Thrombotic Disorders

NCT00178594 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2025-01-09

No results posted yet for this study

Summary

The objective of this study will be to assess the coagulation system in-vitro in a variety of bleeding and clotting disorders using the ROTEG analyzer and the thrombin generation assay.

Conditions

  • Blood Coagulation Disorders, Inherited
  • Thrombotic Disorder

Sponsors & Collaborators

  • The University of Texas Health Science Center, Houston

    lead OTHER

Principal Investigators

  • Miguel Escobar, M.D. · The University of Texas Health Science Center, Houston

Eligibility

Min Age
1 Day
Max Age
98 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-10-31
Primary Completion
2028-01-31
Completion
2028-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00178594 on ClinicalTrials.gov